- Open Access
Locally existing endothelial cells and pericytes in ovarian stroma, but not bone marrow-derived vascular progenitor cells, play a central role in neovascularization during follicular development in mice
© Kizuka-Shibuya et al.; licensee BioMed Central Ltd. 2014
- Received: 18 December 2013
- Accepted: 17 January 2014
- Published: 21 January 2014
Neovascularization is necessary for follicular growth. Vascularization is first observed in preantral follicles, and thereafter the vasculature markedly increases in follicles undergoing development. Neovascularization includes angiogenesis and vasculogenesis. Vasculogenesis is the formation of new blood vessels by bone marrow-derived endothelial progenitor cells. It is unclear whether vasculogenesis occurs during follicular growth. Blood vessels must be mature to be functional blood vessels. Mature blood vessels are characterized by the recruitment of pericytes. However, it is unclear where pericytes come from and whether they contribute to neovascularization in the follicle during follicular growth. In this study, we investigated whether bone marrow-derived progenitor cells that differentiate into vascular endothelial cells or pericytes contribute to neovascularization during follicular growth.
A parabiosis model was used in this study. Six-week-old wild-type and transgenic female mice expressing green fluorescent protein (GFP) were conjoined between the lateral abdominal regions to create a shared circulatory system. After 6 weeks, the ovaries were obtained and immunostained for CD31/CD34 (a vascular endothelial cell marker), platelet-derived growth factor receptor-β (PDGFR-β) (a pericyte marker), and GFP (a bone marrow-derived cell marker).
Cells that were positive for CD34 and PDGFR-β were observed in the stroma adjacent to the primary or early preantral follicles and in the theca cell layer of the follicles from the late preantral stage to the preovulatory stage. CD31/CD34 and GFP double-positive cells were observed in the theca cell layer of the follicle from the antral stage to the preovulatory stage while the number of double-positive cells in the preovulatory follicles did not increase. PDGFR-β and GFP double-positive cells were observed in the theca cell layer of the preovulatory follicle but not in the smaller follicle.
Locally existing endothelial cells and pericytes in the stroma play a central role in the neovascularization during follicular growth, while bone marrow-derived endothelial cells and pericytes partially contribute to this process.
- Follicle growth
- Vascular endothelial cell
Angiogenesis is required for follicular growth during the early follicular developmental stage . Injection of vascular endothelial growth factor (VEGF), a principal angiogenic factor, into the ovarian bursa stimulates the growth of preantral follicles . Inhibition of angiogenesis by VEGF inhibitors prevents the growth of antral follicles, leading to an increased number of atretic follicles and a lack of ovulatory follicles . Suppression of angiogenesis in preantral and early-antral follicles causes follicular atresia at these follicular developmental stages . Furthermore, vascular development also plays a crucial role in the selection and maturation of the dominant follicle destined to ovulate during the late follicular developmental stage . In fact, inhibition of angiogenesis in the late follicular phase interferes with the final stage of follicular development and delays ovulation [5, 6].
Primordial follicles and early-preantral follicles do not have their own individual vascular supply, but instead rely on blood vessels in the surrounding stroma . Soon after the antrum has appeared in the follicle, the follicle acquires a vascular sheath in the theca cell layer [7, 8]. Vascularization is first observed in follicles containing 4 granulosa cell layers (preantral follicles) , and thereafter the vasculature markedly increases in follicles undergoing development from the preantral stage to the antral stage. Regarding the onset of vascularization of the theca cell layer, it has been thought that endothelial cells are recruited to the thecal layer from the blood vessels in the adjacent stroma. Interestingly, we recently found that bone marrow-derived vascular progenitor cells contribute to neovascularization during corpus luteum formation, suggesting the involvement of vasculogenesis in corpus luteum formation . Neovascularization includes angiogenesis and vasculogenesis. Angiogenesis is the development of new blood vessels by endothelial cell proliferation and outgrowth from pre-existing blood vessels. Vasculogenesis refers to new blood vessel formation by bone marrow-derived vascular progenitor cells. Vasculogenesis is a characteristic phenomenon in embryogenesis, but it has been reported to play a role in neovascularization in variety of organs, including those in the adult body [11, 12]. Given this new understanding of adult neovascularization, it is also possible that vasculogenesis is responsible for neovascularization during the follicular growth. Therefore, it is important to investigate whether vasculogenesis occurs during follicular growth.
The vasculature in the follicle delivers oxygen, nutrients, hormones, and bioactive substances for follicular growth and final selection of the dominant follicle. Therefore, blood vessels in the follicle need to stabilize and mature to be functional. Maturation of blood vessels is characterized by the recruitment of pericytes. Pericytes serve as structural components of blood vessels that maintain vascular integrity [13, 14]. Recently, we reported that pericytes are present in the ovary and contribute to neovascularization during the corpus luteum formation in mice  although the presence of pericytes in the rodent ovary has been controversial . However, it is unclear how the pericyte distribution changes during follicular growth, where pericytes come from, and whether pericytes contribute to neovascularization in the follicle during follicular growth. One possibility is that progenitor cells of the pericytes come from the bone marrow and play a role in neovascularization during follicular growth.
In this study, we investigated whether bone marrow-derived progenitor cells that differentiate into vascular endothelial cells or pericytes contribute to neovascularization during follicular growth.
C57BL/6NCrSlc mice were purchased from Japan SLC, Inc., Hamamatsu, Japan. Green fluorescent protein (GFP)-expressing mice (C57BL/6-Tg(CAG-EGFP)), were kindly supplied by Masaru Okabe (Genome Research Center, Osaka University, Osaka, Japan). The mice were housed at 24°C under controlled conditions (lights on from 0500 to 1900 h) under specific pathogen-free conditions and were fed by standard chow and maintained. All experimental protocols were reviewed by the Ethics Committee for Animal Experimentation of Yamaguchi University School of Medicine and carried out according to the Guidelines for Animal Experimentation of the Yamaguchi University School of Medicine and under the Law and Notification requirements of the Japanese Government.
Bone marrow transplantation (BMT) model has generally been used to detect bone marrow-derived vascular progenitor cells. In this model, bone marrow-derived vascular progenitor cells are tracked by transplanting bone marrow cells from GFP-transgenic mice into the recipient mice whose immune systems were compromised by irradiation. The irradiation damages the ovaries , which makes it difficult to examine physiological development of follicles in the BMT model. In addition, when the mice are treated with gonadotropins, the damaged basement membrane of the preovulatory follicle allows vascular endothelial cells to enter the granulosa cell layer before ovulatory LH surge . Furthermore, low dose irradiation is reported to stimulate vasculogenesis in various organs [16, 17]. For these reasons, we used the parabiosis model, in which two mice are conjoined subcutaneously without irradiation and share a common circulation, in order to determine whether endogenous circulating vascular progenitor cells contribute to neovascularization in the follicle during the follicular development.
Wild type mice in the parabiosis model were transcardially perfused with 4% paraformaldehyde in phosphate buffer under inhalation anesthesia using Forane (isoflurane; Abbott Laboratories, IL, USA). For fluorescence-based immunohistochemistry, the ovaries were removed and immersed in phosphate buffer containing 30% sucrose and then embedded in OCT compound (Sakura Finetek Co., Ltd, Tokyo, Japan). Sections (10 μm) were prepared on a cryostat (CM 1850, Leica Microsystems Inc, IL, USA). The fluorescence-based immunohistochemistry was performed as described previously . The primary antibodies used in this study were rat anti-mouse CD31 (an endothelial cell marker; 550274; Becton, Dickinson and company, Franklin Lakes, NJ, USA, dilution 1/50) and rabbit anti-platelet-derived growth factor receptor β antibodies, a pericyte marker (PDGFR-β, dilution 1/2000). Anti-PDGFR-β antibodies were kindly supplied by Dr. William B. Stallcup (Burnham Institute, La Jolla, CA, USA), and the specificity of the rabbit anti-PDGFR-β antibodies is well established [10, 21]. Anti-goat IgG-Alexa594 (Invitrogen Corp., Carlsbad, CA, USA, dilution 1/100) were used as the secondary antibodies. After counterstaining with 4′,6-Diamidino-2-phenylindole (DAPI, 0.5 μg/ml, Invitrogen) the sections were covered with Fluoromount (Diagnostic BioSystems, CA, USA) and observed using a confocal laser microscope (LSM510 META; Carl Zeiss, Oberkochen, Germany). For negative controls, sections were incubated with normal goat serum instead of primary antibodies.
For enzyme-based immunohistochemistry, ovaries were embedded in paraffin. Paraffin-embedded ovaries were sectioned at 4 μm and the sections were deparaffinized in xylene and rehydrated in a graded series of ethanol. The enzyme-based immunohistochemistry was performed as described previously . The primary antibodies used in the enzyme-based immunohistochemistry were rat anti-mouse CD34 (an endothelial cell marker; HM1015; Hycult Biotechnology, Uden, the Netherlands, dilution 1/50) and rabbit anti-PDGFR-β antibodies (dilution 1/1000). When CD34 antibodies were used, the tissues were microwaved at 95°C for 20 min in 0.01 M citrate containing 0.1% Tween 20 epitope retrieval buffer (pH 6.0). The sections were subsequently visualized using ABC (avidin-biotinylated peroxidase complex) system (Vector Laboratories, Inc., Burlingame, CA, USA) with 3,3′-diaminobenzidine tetrahydrochloride (3,3′-DAB), and were counterstained with hematoxylin. For negative controls, sections were incubated with normal goat serum instead of primary antibodies.
Double immunohistochemical staining for GFP and CD34 was performed as described previously with some modifications . Briefly, deparaffinized sections were incubated with the rabbit anti-GFP antibody (ab290; Abcam plc., Cambridge, UK, dilution 1/2000) and subsequently visualized with 3,3′-DAB. After the sections were placed in boiling citric acid buffer (pH 6.0) for 20 min, the slides were incubated with the rat anti-mouse CD34 antibody (dilution 1/50), and visualized by True Blue (KPL, Inc., Gaithersburg, MD, USA). Methyl green was used for counterstaining the nuclei. For double immunostaining for GFP and PDGFR-β, sections were incubated with the rabbit anti-PDGFR-β antibody (dilution 1/200), visualized with DAB solution, reacted with anti-GFP antibody (dilution 1/5000), and then visualized by Vector Blue (Vector Laboratories, Burlingame, CA, USA). No counterstaining was performed in this double immunostaining.
For immunohistochemistry, six to twelve ovaries obtained from three to six parabiosis models were used, and immunostaining was evaluated on three to four tissue sections in each ovary. Developmental stages of follicles were defined by the following criteria: 1) primordial follicle; oocytes surrounded by a single flat layer of follicular somatic cells, 2) primary follicle; oocytes surrounded by a single layer of cuboidal granulosa cells, 3) early preantral follicle; 2–4 layers of granulosa cells, 4) late preantral follicle; more than 4 layers of granulosa cells and no antrum, 5) early antral follicle; each follicle containing an antrum, diameter < 200 μm, 6) late antral follicle; follicle containing an antrum, diameter > 200 μm, and 7) preovulatory follicle .
Angiogenesis plays important roles in the growth of the recruited cohort of small antral follicles in the early follicular developmental stage and subsequent selection of a dominant follicle during the late follicular developmental stage. Vascular endothelial cells form the blood vessels in the follicle, but origin of these cells is unclear. Here, we used a parabiosis model to show the presence of vascular progenitor cells that differentiate into vascular endothelial cells in the follicle of the various developmental stages. This suggests that vasculogenesis at least partly contributes to neovascularization during follicular growth. Vasculogenesis also has roles in neovascularization during corpus luteum formation , uterine endometrial growth , and wound healing [25, 26]. However, in the present study, only a few bone marrow-derived endothelial progenitor cells were observed to be incorporated into the blood vessel of the follicle by vasculogenesis. Furthermore, the numbers of these cells in the follicles did not increase from the early developmental stage to the preovulatory stage, suggesting that bone marrow-derived endothelial cells do not proliferate during follicular growth to form the vascular network of the follicles. Therefore, it appears that locally existing vascular endothelial cells around the follicle in the stroma, rather than bone marrow-derived endothelial cells, are recruited to the theca cell layer and proliferate for neovascularization during the follicular growth. Interestingly, bone marrow-derived endothelial progenitor cells indirectly contribute to neovascularization by stimulating proliferation or invasion of preexisting vascular endothelial cells . Much attention has been given to the involvement of paracrine signals secreted by endothelial progenitor cells in neovascularization, because endothelial progenitor cells produce various angiogenic factors including growth factors and cytokines [25, 27]. Presently, it is thought that the main role of bone marrow-derived endothelial progenitor cells in neovascularization is to stimulate proliferation or invasion of preexisting vascular endothelial cells [25, 27] rather than to directly constitute blood vessels by the mechanism of vasculogenesis [11, 12].
Pericytes contribute to blood vessel stabilization with neovascularization in the ovary [10, 13, 14, 28, 29]. Our results show that pericytes are present around the preantral follicle and in the theca cell layer of the antral follicles (Figure 2), suggesting that pericytes contribute to neovascularization and blood vessel stabilization during follicular growth. Regarding the origin of pericytes in the follicle, our results also show that bone marrow-derived pericytes are present in the theca cell layer of the preovulatory follicles but not in the smaller antral follicles. The presence of bone marrow-derived pericytes in the theca cell layer of the preovulatory follicle is consistent with our recent report . These findings suggest that locally existing pericytes in the stroma, but not bone marrow-derived pericytes, are recruited to the follicle and proliferate during follicular growth. Although the role of bone marrow derived-pericytes in the preovulatory follicle is unclear, they may indirectly contribute to neovascularization by stimulating proliferation or invasion of preexisting vascular endothelial cells [10, 29, 30]. Further studies are needed to clarify the mechanism and role underlying the recruitment of bone marrow derived pericytes to the preovulatory follicle.
Locally existing endothelial cells and pericytes in the stroma play a central role in the neovascularization during follicular growth, while bone marrow-derived endothelial cells and pericytes partially contribute to this process.
We are grateful to Dr. T. Sawada, Dr. K. Sharifi, Mr. M. Tamechika, Dr. K. Udo for their technical assistance. This work was supported in part by JSPS KAKENHI Grant Number 23791846, No. 23890140, 24592471, 24791704, 24791705, 25293343, 25462559, 25462560 and 2586145.
- Zimmermann RC, Xiao E, Bohlen P, Ferin M: Administration of antivascular endothelial growth factor receptor 2 antibody in the early follicular phase delays follicular selection and development in the rhesus monkey. Endocrinology 2002, 143: 2496–2502.View ArticlePubMedGoogle Scholar
- Danforth DR, Arbogast LK, Ghosh S, Dickerman A, Rofagha R, Friedman CI: Vascular endothelial growth factor stimulates preantral follicle growth in the rat ovary. Biol Reprod 2003, 68: 1736–1741.View ArticlePubMedGoogle Scholar
- Wulff C, Wilson H, Wiegand SJ, Rudge JS, Fraser HM: Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor trap R1R2. Endocrinology 2002, 143: 2797–2807.View ArticlePubMedGoogle Scholar
- Garside SA, Henkin J, Morris KD, Norvell SM, Thomas FH, Fraser HM: A thrombospondin-mimetic peptide, ABT-898, suppresses angiogenesis and promotes follicular atresia in pre- and early-antral follicles in vivo. Endocrinology 2010, 151: 5905–5915. 10.1210/en.2010-0283View ArticlePubMedGoogle Scholar
- Zimmermann RC, Xiao E, Husami N, Sauer MV, Lobo R, Kitajewski J, Ferin M: Short-term administration of antivascular endothelial growth factor antibody in the late follicular phase delays follicular development in the rhesus monkey. J Clin Endocrinol Metab 2001, 86: 768–772.PubMedGoogle Scholar
- Zimmermann RC, Hartman T, Kavic S, Pauli SA, Bohlen P, Sauer MV, Kitajewski J: Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle developmen. J Clin Invest 2003, 112: 659–669.PubMed CentralView ArticlePubMedGoogle Scholar
- Findlay JK: Angiogenesis in reproductive tissues. J Endocrinol 1986, 111: 357–366. 10.1677/joe.0.1110357View ArticlePubMedGoogle Scholar
- Fraser HM: Regulation of the ovarian follicular vasculature. Rev Reprod Biol Endocrinol 2006, 4: 18. 10.1186/1477-7827-4-18View ArticleGoogle Scholar
- Wulff C, Wiegand SJ, Saunders PT, Scobie GA, Fraser HM: Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1-Fc (vascular endothelial growth factor Trap (A40)). Endocrinology 2001, 142: 3244–3254.PubMedGoogle Scholar
- Kizuka F, Tokuda N, Takagi K, Adachi Y, Lee L, Tamura I, Maekawa R, Taketani T, Tamura H, Suzuki T, Owada Y, Sugino N: Involvement of bone marrow-derived vascular progenitor cells in neovascularization during formation of the corpus luteum in mice. Biol Reprod 2012,87(3):55. 10.1095/biolreprod.112.099960View ArticlePubMedGoogle Scholar
- Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275: 964–967. 10.1126/science.275.5302.964View ArticlePubMedGoogle Scholar
- Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85: 221–228. 10.1161/01.RES.85.3.221View ArticlePubMedGoogle Scholar
- Sugino N, Suzuki T, Sakata A, Miwa I, Asada H, Taketani T, Yamagata Y, Tamura H: Angiogenesis in the human corpus luteum: changes in expression of angiopoietins in the corpus luteum throughout the menstrual cycle and in early pregnancy. J Clin Endocrinol Metab 2005, 90: 6141–6148. 10.1210/jc.2005-0643View ArticlePubMedGoogle Scholar
- Sugino N, Matsuoka A, Taniguchi K, Tamura H: Angiogenesis in the human corpus luteum. Reprod Med Biol 2008, 7: 91–103. 10.1111/j.1447-0578.2008.00205.xView ArticleGoogle Scholar
- Matsuoka-Sakata A, Tamura H, Asada H, Miwa I, Taketani T, Yamagata Y, Sugino N: Changes in vascular leakage and expression of angiopoietins in the corpus luteum during pregnancy in rats. Reproduction 2006, 131: 351–360. 10.1530/rep.1.00947View ArticlePubMedGoogle Scholar
- Chang CC, Lerman OZ, Thanik VD, Scharf CL, Greives MR, Schneider RJ, Formenti SC, Saadeh PB, Warren SM, Levine JP: Dose-dependent effect of radiation on angiogenic and angiostatic CXC chemokine expression in human endothelial cells. Cytokine 2009, 48: 295–302. 10.1016/j.cyto.2009.08.007View ArticlePubMedGoogle Scholar
- Kozin SV, Kamoun WS, Huang Y, Dawson MR, Jain RK, Duda DG: Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation. Cancer Res 2010, 70: 5679–5685. 10.1158/0008-5472.CAN-09-4446PubMed CentralView ArticlePubMedGoogle Scholar
- Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL: Physiological migration of hematopoietic stem and progenitor cells. Science 2001, 294: 1933–1936. 10.1126/science.1064081View ArticlePubMedGoogle Scholar
- Tanaka K, Sata M, Natori T, Kim-Kaneyama JR, Nose K, Shibanuma M, Hirata Y, Nagai R: Circulating progenitor cells contribute to neointimal formation in nonirradiated chimeric mice. FASEB J 2008, 22: 428–436.View ArticlePubMedGoogle Scholar
- Owada Y, Abdelwahab SA, Kitanaka N, Sakagami H, Takano H, Sugitani Y, Sugawara M, Kawashima H, Kiso Y, Mobarakeh JI, Yanai K, Kaneko K: Altered emotional behavioral responses in mice lacking brain-type fatty acid-binding protein gene. Eur J Neurosci 2006, 24: 175–187. 10.1111/j.1460-9568.2006.04855.xView ArticlePubMedGoogle Scholar
- Song S, Ewald AJ, Stallcup W, Werb Z, Bergers G: PDGFRbeta + perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol 2005, 7: 870–879. 10.1038/ncb1288PubMed CentralView ArticlePubMedGoogle Scholar
- Suzuki T, Sasano H, Takaya R, Fukaya T, Yajima A, Nagura H: Cyclic changes of vasculature and vascular phenotypes in normal human ovaries. Hum Reprod 1998, 13: 953–959. 10.1093/humrep/13.4.953View ArticlePubMedGoogle Scholar
- Butcher RL, Kirkpatrick-Keller D: Pattern of follicular growth during the four-day estrous cycle of the rat. Biol Reprod 1984, 31: 280–286. 10.1095/biolreprod31.2.280View ArticlePubMedGoogle Scholar
- Masuda H, Kalka C, Takahashi T, Yoshida M, Wada M, Kobori M, Itoh R, Iwaguro H, Eguchi M, Iwami Y, Tanaka R, Nakagawa Y: Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ Res 2007, 101: 598–606. 10.1161/CIRCRESAHA.106.144006View ArticlePubMedGoogle Scholar
- Alev C, Ii M, Asahara T: Endothelial progenitor cells: a novel tool for the therapy of ischemic diseases. Antioxid Redox Signal 2011, 15: 949–965. 10.1089/ars.2010.3872View ArticlePubMedGoogle Scholar
- Ii M, Nishimura H, Iwakura A, Wecker A, Eaton E, Asahara T, Losordo DW: Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via “imported” nitric oxide synthase activity. Circulation 2005, 111: 1114–1120. 10.1161/01.CIR.0000157144.24888.7EView ArticlePubMedGoogle Scholar
- Krenning G, van Luyn MJ, Harmsen MC: Endothelial progenitor cell-based neovascularization: implications for therapy. Trends Mol Med 2009, 15: 180–189. 10.1016/j.molmed.2009.02.001View ArticlePubMedGoogle Scholar
- Kuhnert F, Tam BY, Sennino B, Gray JT, Yuan J, Jocson A, Nayak NR, Mulligan RC, McDonald DM, Kuo CJ: Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis. Proc Natl Acad Sci U S A 2008, 105: 10185–10190. 10.1073/pnas.0803194105PubMed CentralView ArticlePubMedGoogle Scholar
- Redmer DA, Doraiswamy V, Bortnem BJ, Fisher K, Jablonka-Shariff A, Grazul-Bilska AT, Reynolds LP: Evidence for a role of capillary pericytes in vascular growth of the developing ovine corpus luteum. Biol Reprod 2001, 65: 879–889. 10.1095/biolreprod65.3.879View ArticlePubMedGoogle Scholar
- Tigges U, Hyer EG, Scharf J, Stallcup WB: FGF2-dependent neovascularization of subcutaneous matrigel plugs is initiated by bone marrow-derived pericytes and macrophages. Development 2008, 135: 523–532. 10.1242/dev.002071View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.